Buprenorphine/Naloxone Dose, Stress, and Opioid Use
About this title
Read the official source — NCT03015246Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
What did participation involve?
The study compares medication regimens involving extended-release morphine or buprenorphine/naloxone. Within those groups, the protocol also compares a medication-induced stress procedure with a placebo (an inactive comparison treatment) procedure.
- Listed locations
- Overland ParkSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 26
- Sponsor
- Wayne State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03015246
- Official title
Show the full official title
Biobehavioral Studies of Opioid Seeking: Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Overland Park
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to take study medication.
Who is behind this study?
The study sponsor is Wayne State University, a university.
Did this study involve medication?
Yes. The study involved medication, including Extended release morphine, Buprenorphine/Naloxone low dose, Buprenorphine/Naloxone moderate dose, Buprenorphine/Naloxone high dose, Active stressor and Placebo stressor.
Who was this study for?
Listed age limits: 18 years to 55 years.
